How to integrate current knowledge in selecting patients for first line in NSCLC? [electronic resource]
Producer: 20111017Description: vii230-3 p. digitalISSN:- 1569-8041
- Angiogenesis Inhibitors -- therapeutic use
- Carcinoma, Non-Small-Cell Lung -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Health Knowledge, Attitudes, Practice
- Humans
- Lung Neoplasms -- genetics
- Neoadjuvant Therapy -- methods
- Patient Selection
- Protein Kinase Inhibitors -- therapeutic use
- Systems Integration
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.